Exploring Lamotrigine's Cardiac Safety Profile

This chapter examines the cardiac effects of Lamotrigine, focusing on concerns like QTC prolongation and QRS widening as highlighted by FDA warnings. It presents evidence from studies showing that Lamotrigine does not significantly affect the QTC interval at therapeutic doses and compares the severity of QRS widening to tricyclic antidepressants, offering healthcare professionals valuable insights for patient counseling.